CAMBRIDGE, Mass., Jan. 3, 2025 /PRNewswire/ - VBI Vaccines Inc. ("VBI" or the "Company") today announced, that, in connection with its creditor protection proceedings under the Companies ...
VBI Vaccines ( (VBIVQ) ) has shared an announcement.
A biotechnology firm in Durham is expanding its portfolio with an $18 million deal. STORY HIGHLIGHTS Brii Biosciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback